High mobility group protein HMGA1 expression in breast cancer reveals a positive correlation with tumour grade

Histology and Histopathology

Volumn 18, Issue 4, 2003, Pages 999-1004

  Flohr, A M ^a   Rogalla, P ^a,e   Bonk, U ^b   Puettmann, B ^a   Buerger, H ^c   Gohla, G ^b   Packeisen, J ^d   Wosniok, W ^a   Loeschke, S ^a,b   Bullerdiek, J ^a  

^a UNIVERSITY OF BREMEN   (Germany)

^b Central Hospital   (Germany)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^d Hochschule Osnabrueck   (Germany)

^e Alcedo Biotech   (Germany)

Author keywords

Breast cancer; High mobility group proteins; HMGA1 expression; Immunoreactive score (IRS); Prognostic marker

Indexed keywords

HIGH MOBILITY GROUP A PROTEIN; HIGH MOBILITY GROUP A1 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER CLASSIFICATION; CANCER GRADING; CONTROLLED STUDY; CORRELATION ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MEDULLARY CARCINOMA; MUCINOUS CARCINOMA; PAPILLARY CARCINOMA; PROGNOSIS; PROTEIN EXPRESSION; STATISTICAL ANALYSIS;

BREAST NEOPLASMS; FEMALE; HMGA1A PROTEIN; HUMANS; IMMUNOHISTOCHEMISTRY; PARAFFIN EMBEDDING;

EID: 12444329821     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Abe N., Watanabe T., Masaki T., Mori T., Sugiyama M., Uchimura H., Fujioka Y., Chiappetta G., Fusco A. and Atomi Y. (2000). Pancreatic duct cell carcinomas express high levels of high mobility group I(Y) proteins. Cancer Res. 60, 3117-3122.
2. Abe N., Watanabe T., Sugiyama M., Uchimura H., Chiappetta G., Fusco A. and Atomi Y. (1999). Determination of high mobility group I(Y) expression level in colorectal neoplasias: A potential diagnostic marker. Cancer Res. 59, 1169-1174.
3. Bandiera A., Bonifacio D., Manfioletti G., Mantovani F., Rustighi A., Zanconati F., Fusco A., Di Bonito L. and Giancotti V. (1998). Expression of HMGI(Y) proteins in squamous intraepithelial and invasive lesions of the uterine cervix. Cancer Res. 58, 426-431.
4. Banks G.C., Li Y. and Reeves R. (2000). Differential in vivo modifications of the HMGI(Y) nonhistone chromatin proteins modulate nucleosome and DNA interactions. Biochemistry 39, 8333-8346.
5. Bustin M. (2001). Revised nomenclature for high mobility group (HMG) chromosomal proteins. Trends Biochem. Sci. 26, 152-153.
6. Chiappetta G., Avantaggiato V., Visconti R., Fedele M., Battista S., Trapasso F., Merciai B.M., Fidanza V., Giancotti V., Santoro M., Simeone A. and Fusco A. (1996). High level expression of the HMGI(Y) gene during embryonic development. Oncogene 13, 2439-2446.
7. Chiappetta G., Bandiera A., Berlingieri M.T., Visconti R., Manfioletti G., Battista S., Martinez-Tello F.J., Santoro M., Giancotti V. and Fusco A. (1995). The expression of the high mobility group HMGI (Y) proteins correlates with the malignant phenotype of human thyroid neoplasias. Oncogene 10, 1307-1314.
8. Chiappetta G., Tallini G., De Biasio M.C., Manfioletti G., Martinez-Tello FJ., Pentimalli F., De Nigris F., Mastro A., Botti G., Fedele M., Berger N., Santoro M., Giancotti V. and Fusco A. (1998). Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma. Cancer Res. 58, 4193-4198.
9. Dolde C.E., Mukherjee M., Cho C. and Resar L.M. (2002). HMG-I/Y in human breast cancer cell lines. Breast Cancer Res. Treat. 71, 181-191.
10. Fedele M., Bandiera A., Chiappetta G., Battista S., Viglietto G., Manfioletti G., Casamassimi A., Santoro M., Giancotti V. and Fusco A. (1996). Human colorectal carcinomas express high levels of high mobility group HMGI(Y) proteins. Cancer Res. 56, 1896-1901.
11. Friedmann M., Holth L.T., Zoghbi H.Y. and Reeves R. (1993). Organization, inducible-expression and chromosome localization of the human HMG-I(Y) nonhistone protein gene. Nucleic Acids Res. 21, 4259-4267.
12. Holth L.T., Thorlacius A.E. and Reeves R. (1997). Effects of epidermal growth factor and estrogen on the regulation of the HMG-I/Y gene in human mammary epithelial cell lines. DNA Cell. Biol. 16, 1299-1309.
13. Kazmierczak B., Dal Cin P., Wanschura S., Borrmann L., Fusco A., Van Den Berghe H. and Bullerdiek J. (1998). HMGIY is the target of 6p21.3 rearrangements in various benign mesenchymal tumors. Genes Chromosomes Cancer 23, 279-285.
14. Kononen J., Bubendorf L., Kallioniemi A., Barlund M., Schraml P., Leighton S., Torhorst J., Mihatsch M.J., Sauter G. and Kallioniemi O.P. (1998). Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat. Med. 4, 844-847.
15. Liu F., Chau K.Y., Arlotta P. and Ono S.J. (2001). The HMG I proteins: Dynamic roles in gene activation, development, and tumorigenesis. Immunol. Res. 24, 13-29.
16. Liu W.M., Guerra-Vladusic F.K., Kurakata S., Lupu R. and Kohwi-Shigematsu T. (1999). HMG-I(Y) recognizes base-unpairing regions of matrix attachment sequences and its increased expression is directly linked to metastatic breast cancer phenotype. Cancer Res. 59, 5695-5703.
17. Nacht M., Ferguson A.T., Zhang W., Petroziello J.M., Cook B.P., Gao Y.H., Maguire S., Riley D., Coppola G., Landes G.M., Madden S.L. and Sukumar S. (1999). Combining serial analysis of gene expression and array technologies to identify genes differentially expressed in breast cancer. Cancer Res. 59, 5464-5470.
18. Ram T.G., Reeves R. and Hosick H.L. (1993). Elevated high mobility group-I(Y) gene expression is associated with progressive transformation of mouse mammary epithelial cells. Cancer Res. 53, 2655-2660.
19. Reeves R. and Beckerbauer L. (2001). HMGI/Y proteins: Flexible regulators of transcription and chromatin structure. Biochim. Biophys. Acta 1519, 13-29.
20. Reeves R., Edberg D.D. and Li Y. (2001). Architectural transcription factor HMGI(Y) promotes tumor progression and mesenchymal transition of human epithelial cells. Mol. Cell. Biol. 21, 575-594.
21. Remmele W. (1997). Pathologie. 2nd Edition. Springer publisher. Berlin.
22. Remmele W. and Stegner H.E. (1987). Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe 8, 138-140.
23. Rosen P.P. and Oberman H.A. (1993). Atlas of Tumor Pathology. Tumors of the Mammary Gland. Armed Forces Institute of Pathology Washington D C.
24. Scala S., Portella G., Fedele M., Chiappetta G. and Fusco A. (2000). Adenovirus-mediated suppression of HMGI(Y) protein synthesis as potential therapy of human malignant neoplasias. Proc. Natl. Acad. Sci. USA 97, 4256-4261.
25. Tallini G., Vanni R., Manfioletti G., Kazmierczak B., Faa G., Pauwels P., Bullerdiek J., Giancotti V., Van Den Berghe H. and Dal Cin P. (2000). HMGI-C and HMGI(Y) immunoreactivity correlates with cytogenetic abnormalities in lipomas, pulmonary chondroid hamartomas, endometrial polyps, and uterine leiomyomas and is compatible with rearrangement of the HMGI-C and HMGI(Y) genes. Lab. Invest. 80, 359-369.
26. Tamimi Y., Van Der Poel H.G., Denyn M.M., Umbas R., Karthaus H.F., Debruyne F.M. and Schalken J.A. (1993). Increased expression of high mobility group protein I(Y) in high grade prostatic cancer determined by in situ hybridization. Cancer Res. 53, 5512-5516.
27. Williams A.J., Powell W.L., Collins T. and Morton C.C. (1997). HMGI(Y) expression in human uterine leiomyomata. Involvement of another high-mobility group architectural factor in a benign neoplasm. Am. J. Pathol. 150, 911-918.
28. Wood L.J., Maher J.F., Bunton T.E. and Resar L.M. (2000a). The oncogenic properties of the HMG-I gene family. Cancer Res. 60, 4256-4261.
29. Wood L.J., Mukherjee M., Dolde C.E., Xu Y., Maher J.F., Bunton T.E., Williams J.B. and Resar L.M. (2000b). HMG-I/Y, a new c-Myc target gene and potential oncogene. Mol. Cell. Biol. 20, 5490-5502.